Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Polymorphism of the osteopontin gene and clinical course of multiple sclerosis in the Polish population.
[Hypomyelination with atrophy of the basal ganglia and cerebellum. Contribution of two new cases to a recently reported entity].
Role of toll-like receptor 2 in ischemic demyelination and oligodendrocyte death.
MRI evaluation of grey matter atrophy and disease course in multiple sclerosis: an overview of current knowledge.
Claudin Proteins And Neuronal Function.
Synchrony analysis: application in early diagnosis, staging and prognosis of multiple sclerosis.
Neuropathic pain in neuromyelitis optica affects activities of daily living and quality of life.
Walking while talking in patients with multiple sclerosis: The impact of specific cognitive loads.
Deficient phosphorylation of stat1 in leukocytes identifies neutralizing antibodies in multiple sclerosis patients treated with interferon-Beta.
Review: In relapsing-remitting multiple sclerosis, disease-modifying agents reduce annual relapse rates.
Swimming exercise ameliorates multiple sclerosis-induced impairment of short-term memory by suppressing apoptosis in the hippocampus of rats.
Cognitive and brain reserve for mind-body therapeutic approaches in multiple sclerosis: A review.
Impaired Cerebrovascular Reactivity in Multiple Sclerosis.
Protein kinase C polymorphisms and vitamin D levels in multiple sclerosis.
Plasma levels of neuron specific enolase quantify the extent of neuronal injury in murine models of ischemic stroke and multiple sclerosis.
Glutamate signaling in benign and malignant disorders: current status, future perspectives, and therapeutic implications.
Autoantigens and autoantibodies in multiple sclerosis.
Multicentre absolute myelin water content mapping: Development of a whole brain atlas and application to low-grade multiple sclerosis.
[Acute disseminated encephalomyelitis and multiple sclerosis: open questions of differential diagnosis demonstrated by the example of a clinical case.]
Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis.
Smoking as a risk factor for multiple sclerosis.
The Multiple Sclerosis Intimacy and Sexuality Questionnaire -- re-validation and development of a 15-item version with a large US sample.
A PheWAS approach in studying HLA-DRB1*1501.
Acceptance of pain in neurological disorders: Associations with functioning and psychosocial well-being.
Cognitive Impairment in Multiple Sclerosis: A Forgotten Disability Remembered.

Pages